The present disclosure relates generally to methods of treatment of Clostridium difficile-associated disorders and/or C. difficile spores in the gastrointestinal tract by administering ramoplanin or a pharmaceutical formulation thereof, pharmaceutical compositions comprising ramoplanin, and therapeutic uses thereof in treating Clostridium difficile-associated disorders and/or C. difficile spores.